🔎 Trials Near Me

Domov › Velika depresivna motnja › Florida › Miami

Klinične študije za Velika depresivna motnja v Miami, FL

18 študij za Velika depresivna motnja išče udeležence na lokacijah v Miami in okolici (v razdalji približno 30 milj). Odprite študijo, da vidite, kdo lahko sodeluje in kako kontaktirati ekipo.

Uradno besedilo študije (angleško)

Iščete udeležence za študijo? Predstavite jo na vrhu te strani — $99 za 30 dni →

A Study of Brenipatide (LY3537031) in Adult Participants With Major Depressive Disorder

Vključevanje udeležencevFaza 3
  • Miami Jewish health, Miami
  • Quantix Research - Miami - Southwest 72nd Street, Miami
  • Diverse Clinical Research, Miami
Starost 18–75 · Vsi spoli · Posodobljeno 1. okt. 2026 · NCT07775300

A Study of Seltorexant as Monotherapy in Adults and Elderly Participants With Major Depressive Disorder

Vključevanje udeležencevFaza 3
  • Pharmax Research Clinic Inc, Miami
  • Nuovida Research Center, Miami
Starost 18–74 · Vsi spoli · Posodobljeno 1. okt. 2026 · NCT07573176

Phase 3 Study of Adjunctive Treatment With Seltorexant in Adult and Elderly Participants With Major Depressive Disorder and Insomnia Symptoms

Vključevanje udeležencevFaza 3
  • Pharmax Research Clinic Inc, Miami
  • Miami Dade Medical Research Institute, Miami
  • Nuovida Research Center, Miami
Starost 18–74 · Vsi spoli · Posodobljeno 25. sep. 2026 · NCT06559306

A Study to Evaluate TNX-102 SL Monotherapy Versus Placebo in Participants With Major Depressive Disorder (MDD)

Vključevanje udeležencevFaza 2
  • Central Miami Medical Institute Llc., Miami
Starost 18 in več · Vsi spoli · Posodobljeno 25. sep. 2026 · NCT07621237

Study of Lumateperone as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder

Vključevanje udeležencevFaza 3
  • Premier Clinical Research Institute, Miami
  • Miami Jewish Health System, Miami
Starost 18–65 · Vsi spoli · Posodobljeno 25. sep. 2026 · NCT05850689

Evaluation of Efficacy and Safety of Milsaperidone as Adjunctive Therapy in Patients With Major Depressive Disorder

Vključevanje udeležencevFaza 3
  • Vanda Investigational Site, Miami
Starost 18–65 · Vsi spoli · Posodobljeno 24. sep. 2026 · NCT06830044

A Study to Evaluate the Effectiveness of DT-101 in Patients With Depression

Vključevanje udeležencevFaza 2
  • Draig Clinical Site, Miami
Starost 18–75 · Vsi spoli · Posodobljeno 26. avg. 2026 · NCT07300969

NBI-1065845-MDD3026: Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)

Vključevanje udeležencevFaza 3
  • Neurocrine Clinical Site, Miami
Starost 18 in več · Vsi spoli · Posodobljeno 10. avg. 2026 · NCT06963021

A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder

Vključevanje udeležencevFaza 3
  • PharmaSouth Research, Miami
Starost 18–74 · Vsi spoli · Posodobljeno 3. avg. 2026 · NCT06775379

Zelquistinel or Placebo for the Reduction of Symptoms of Major Depressive Disorder

Vključevanje udeležencevFaza 2
  • Premier Clinical Research Institute, Inc., Miami
  • Miami Dade Medical Research Institute, Miami
Starost 18–64 · Vsi spoli · Posodobljeno 3. avg. 2026 · NCT06547489

A Phase 2 Study of Zelquistinel or Placebo for the Reduction of Symptoms of Major Depressive Disorder

Vključevanje udeležencevFaza 2
  • Premier Clinical Research Institute Inc, Miami
Starost 18–64 · Vsi spoli · Posodobljeno 27. jul. 2026 · NCT07115329

Long-Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)

Vključevanje udeležencevFaza 3
  • Neurocrine Clinical Site, Miami
Starost 18 in več · Vsi spoli · Posodobljeno 24. jul. 2026 · NCT06966401

Clinical Assessment of Response in the Treatment of Depression With Daytime Sleepiness Using Solriamfetol

Vključevanje udeležencevFaza 3
  • Clinical Research Site, Miami
  • Clinical Research Site, Miami
Starost 18–65 · Vsi spoli · Posodobljeno 24. jul. 2026 · NCT07484217

A Study to Assess Change in Disease Activity and Adverse Events of Oral Icalcaprant in Adult Participants With Major Depressive Disorder

Vključevanje udeležencevFaza 2
  • GMI Florida - Central Miami Medical Institute /ID# 278218, Miami
Starost 18–65 · Vsi spoli · Posodobljeno 15. jun. 2026 · NCT07276997

A Study to Assess the Efficacy, Safety and Tolerability of VLS-01 Buccal Film, Compared to Placebo in Patients With Treatment Resistant Depression (ELUMINA)

Vključevanje udeležencevFaza 2
  • Bioresearch Partner, Miami
Starost 18–65 · Vsi spoli · Posodobljeno 11. maj 2026 · NCT06524830

Study of ABX-002 for the Adjunctive Treatment of Major Depressive Disorder (AMPLIFY)

Vključevanje udeležencevFaza 2
  • Autobahn Site #111, Miami
Starost 18–65 · Vsi spoli · Posodobljeno 20. jan. 2026 · NCT06633016

A Study to Evaluate the Efficacy of AXS-05 Compared to Bupropion in Preventing the Relapse of Depressive Symptoms

Vključevanje udeležencevFaza 4
  • Clinical Research Site, Miami
Starost 18–65 · Vsi spoli · Posodobljeno 23. jan. 2025 · NCT06223880

Študije za Velika depresivna motnja v drugih mestih

Druge študije v Miami

Vir: ClinicalTrials.gov, podatki pridobljeni 5. okt. 2026. Vsaka študija ima svoje pogoje vključitve; ekipa študije odloči, kdo lahko sodeluje.